Pulse Biosciences, Inc Common Stock (DE) PLSE

$52.90 +1.26% at last close
Market Cap$3.77 billion
P/E Ratio—
Div Yield—
Volume250.7K
52-Week Range $12.56$58.90

Analyst Ratings

Consensus
Buy — 5 Buy · 0 Hold · 0 Sell (5 analysts)
Avg. Price Target
$63.80 (+20.6% upside)

Full PLSE forecast & analyst actions →

Key Stats

Today's Range
$51.32 – $53.85
50-Day Range
$43.32 – $58.90
52-Week Range
$12.56 – $58.90
Volume
251K shs
Average Volume
421K shs
Market Cap
$3.77 billion
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
2.19%
Days to Cover
12.05

About Pulse Biosciences, Inc Common Stock (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
116
Exchange
XNAS
Listed
2016-05-18

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.